therascreen EGFR RGQ PCR Kit
FDA-approved real-time PCR companion diagnostic for EGFR mutation testing in non-small cell lung cancer.
- Developer
- QIAGEN
- Intended use
- Other
- Cancer scope
- Non-small cell lung cancer
- Specimen
- FFPE tumor tissue
- Molecular modality
- DNA mutation
- Current version
- Current U.S. therascreen EGFR RGQ PCR Kit device family, PMA P120022 with indication-specific supplements (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.